CollPlant Biotechnologies... (CLGN)
3.06
0.01 (0.33%)
At close: Mar 06, 2025, 2:03 PM
3.04
-0.65%
After-hours: Mar 06, 2025, 02:03 PM EST
CollPlant Biotechnologies Ltd. Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 10.96M | 299K | 15.64M | 6.14M | 2.32M | 4.79M | 479.92K | 75.91K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.99M | 400K | 2M | 3M | 1.88M | 378.63K | 14.96K | 225.07K | 202.82K | n/a | n/a | n/a |
| Gross Profit | 8.97M | -101K | 13.64M | 3.13M | 439K | 4.41M | 464.96K | -149.16K | -202.82K | n/a | n/a | n/a |
| Operating Income | -7.51M | -17.1M | 65K | -5.6M | -7.63M | -4.07M | -5.97M | -7.16M | -4.82M | -3.5M | -4.65M | -4.64M |
| Interest Income | 788K | 321K | 219K | 40K | 10K | 438.11K | 72.79K | n/a | n/a | 8.99K | 7.18K | 27.57K |
| Pretax Income | -7.02M | -16.93M | 237K | -5.77M | -11.16M | -3.69M | -6.01M | -7.25M | -4.78M | -3.34M | -4.73M | -4.6M |
| Net Income | -7.02M | -16.75M | 409K | -5.81M | -14.7M | -6.25M | -6.05M | -7.24M | -4.79M | -3.34M | -4.75M | -4.6M |
| Selling & General & Admin | 6M | 6.74M | 5.94M | 4.67M | 3.62M | 3.29M | 2.38M | 2.86M | 1.77M | 987.43K | 1.05M | 1.35M |
| Research & Development | 10.48M | 10.26M | 7.63M | 4.07M | 4.41M | 5.16M | 4.05M | 4.36M | 3.04M | 2.5M | 3.57M | 3.27M |
| Other Expenses | n/a | n/a | n/a | n/a | 33K | 21.51K | 13.52K | 9.88K | 6.4K | 15.66K | 29.29K | 16.33K |
| Operating Expenses | 16.48M | 17M | 13.57M | 8.73M | 8.07M | 8.48M | 6.44M | 7.24M | 4.82M | 3.5M | 4.65M | 4.64M |
| Interest Expense | 10K | 34K | 37K | 34K | 63K | 15.13K | 21.58K | 33.48K | 13.06K | 6.42K | 7.75K | 11.78K |
| Selling & Marketing Expenses | n/a | n/a | n/a | 48K | n/a | n/a | n/a | n/a | n/a | 42.37K | 36.18K | 66.92K |
| Cost & Expenses | 18.47M | 17.4M | 15.58M | 11.74M | 9.95M | 8.85M | 6.45M | 7.24M | 4.82M | 3.5M | 4.65M | 4.64M |
| Income Tax | n/a | -172K | -172K | 34K | 3.53M | 2.96M | 28.44K | -86.28K | 63.85K | 162.84K | -54.91K | 56.02K |
| Shares Outstanding (Basic) | 11.39M | 11.03M | 9.97M | 6.89M | 4.99M | 4.38M | 2.66M | 2.01M | 1.69M | 1.61M | 1.04M | 856.97K |
| Shares Outstanding (Diluted) | 11.39M | 11.03M | 11.97M | 6.89M | 4.99M | 4.38M | 2.66M | 2.01M | 1.69M | 1.61M | 1.04M | 856.97K |
| EPS (Basic) | -0.62 | -1.52 | 0.04 | -0.84 | -2.95 | -1.43 | -2.27 | -3.6 | -2.83 | -2.08 | -4.56 | -5.37 |
| EPS (Diluted) | -0.62 | -1.52 | 0.03 | -0.84 | -2.95 | -1.43 | -2.27 | -3.6 | -2.83 | -2.08 | -4.56 | -5.37 |
| EBITDA | -6.41M | -16.02M | 838K | -4.94M | -7.09M | -3.9M | -5.73M | -6.95M | -4.6M | -3.41M | -4.3M | -4.14M |
| Depreciation & Amortization | 1.1M | 1.08M | 773K | 660K | 539K | 342K | 291.63K | 225.07K | 201.86K | 205.96K | 273.08K | 326.82K |